United States
Print page content Print
Increase text size Decrease text size
Text Size
CYTOPOINT - now approved for the treatment of allergic dermatitis! Learn more

Treat skin infection

Treat skin infection

Skin infection can disrupt the pet-owner
connection—protect the bond with CONVENIA Convenia

Continue APOQUEL (oclacitinib tablet) and treat with CONVENIA if you identify a Staph pyoderma due to allergic dermatitis

Fast-acting

  • A single SQ injection provides rapid and complete absorption for resolution of bacterial skin infections1

First-time treatment success

  • 86% of dogs needed only one injection to resolve their skin infections1
  • Dosing simplifies life for clients, eliminates compliance challenges and gives you peace of mind so you can focus on other areas of the diagnostic workup

A single injection provides antibiotic treatment for up to 14 days*

CONVENIA single injection

Gunner’s story2

  • 12-year-old male Golden Retriever
  • Gunner developed a severe allergy, which quickly escalated to a large, distressing hot spot that alarmed his owner
  • Gunner was diagnosed with pyoderma secondary to allergic dermatitis and given CONVENIA for the infection and a first dose of APOQUEL for the itch while he was still in the clinic
  • Within 24 hours, Gunner had stopped scratching and rolling on the floor and was lively and playful again

Relief protects the bond

APOQUEL and CONVENIA are the new standard of care, in my opinion. With the anti-itch therapy as well as the antibiotic therapy, you’re taking care of both conditions at the same time very effectively and quickly.

John Hutchens, DVM

In clinical studies, a single injection of CONVENIA was clinically equivalent to a 14-day antibiotic regimen.

CONVENIA Indications: CONVENIA is indicated for the treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis.

CONVENIA Important Safety Information: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to CONVENIA. Do not use in dogs or cats with a history of allergic reactions to penicillins or cephalosporins. Side effects for both dogs and cats include vomiting, diarrhea, decreased appetite/anorexia and lethargy.

For more information, please see the full Prescribing Information.

APOQUEL Indications: Control of pruritus associated with allergic dermatitis and control of atopic dermatitis in dogs at least 12 months of age.

APOQUEL Important Safety Information: Do not use APOQUEL in dogs less than 12 months of age or those with serious infections. APOQUEL may increase the chances of developing serious infections, and may cause existing parasitic skin infestations or pre-existing cancers to get worse. APOQUEL has not been tested in dogs receiving some medications including some commonly used to treat skin conditions such as corticosteroids and cyclosporine. Do not use in breeding, pregnant, or lactating dogs. Most common side effects are vomiting and diarrhea. APOQUEL has been used safely with many common medications including parasiticides, antibiotics and vaccines.

For more information, please see the full Prescribing Information.

References: 1. Six R, Cherni J, Chesebrough R, et al. Efficacy and safety of cefovecin in treating bacterial folliculitis, abscesses, or infected wounds in dogs. J Am Vet Med Assoc. 2008;233(3):433-439. 2. Data on file, Pet Owner Cases—Bijou, Gunner, Nani, Captain and Molly, Zoetis Inc.

The animal health information contained herein is provided for educational purposes only and is not intended to replace discussions with an animal healthcare professional. All decisions regarding the care of a veterinary patient must be made with an animal healthcare professional, considering the unique characteristics of the patient.

The product information provided in this site is intended only for residents of the United States. The products discussed herein may not have marketing authorization or may have different product labeling in different countries.

All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted.
© 2018 Zoetis Services LLC. All rights reserved ZPC-00064